Zhu M, Juorio A, Paterson I, Boulton A
Br J Pharmacol. 1994; 112(1):23-30.
PMID: 7913379
PMC: 1910301.
DOI: 10.1111/j.1476-5381.1994.tb13023.x.
Rastogi R, Singhal R, Lapierre Y
J Neural Transm. 1981; 50(2-4):139-48.
PMID: 7241114
DOI: 10.1007/BF01249135.
Cheal M
Psychopharmacology (Berl). 1980; 69(1):93-100.
PMID: 6771833
DOI: 10.1007/BF00426528.
McQuade P, Juorio A
Neurochem Res. 1983; 8(7):903-12.
PMID: 6621777
DOI: 10.1007/BF00964551.
van Oene J, DE VRIES J, Horn A
Naunyn Schmiedebergs Arch Pharmacol. 1984; 327(4):304-11.
PMID: 6514014
DOI: 10.1007/BF00506241.
[Nerve cell clonal lines in culture--models for studying the molecular basis of neuropharmacological actions].
Herken H
Klin Wochenschr. 1983; 61(1):1-16.
PMID: 6187966
DOI: 10.1007/BF01484434.
Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine.
Laschinski G, Kittner B, Brautigam M
Naunyn Schmiedebergs Arch Pharmacol. 1984; 327(2):114-8.
PMID: 6149468
DOI: 10.1007/BF00500904.
Dopa-release from mouse neuroblastoma clone N 1 E-115 into the culture medium. A test for tyrosine hydroxylase activity.
Brautigam M, Dreesen R, Herken H
Naunyn Schmiedebergs Arch Pharmacol. 1982; 320(2):85-9.
PMID: 6126821
DOI: 10.1007/BF00506305.
Intracranial self-stimulation in rats as a function of various stimulus parameters. 3. Influence of apomorphine on medial forebrain bundle stimulation with monopolar electrodes.
Wauquier A, NIEMEGEERS C
Psychopharmacologia. 1973; 30(2):163-72.
PMID: 4711373
DOI: 10.1007/BF00421431.
Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis.
Carlsson A, Engel J, Strombom U, Svensson T, WALDECK B
Naunyn Schmiedebergs Arch Pharmacol. 1974; 283(2):117-28.
PMID: 4278296
DOI: 10.1007/BF00501138.
[Brain amines and apomorphine-induced intraspecific aggressive behavior in the rat (author's transl)].
SENAULT B
Psychopharmacologia. 1974; 34(2):143-54.
PMID: 4274176
DOI: 10.1007/BF00421939.
Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acid.
ANDEN N, Magnusson T, Stock G
Naunyn Schmiedebergs Arch Pharmacol. 1973; 278(4):363-72.
PMID: 4269969
DOI: 10.1007/BF00501480.
The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat.
Costall B, Naylor R
Naunyn Schmiedebergs Arch Pharmacol. 1973; 278(2):117-33.
PMID: 4268638
DOI: 10.1007/BF00500645.
Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.
Clark D, Hjorth S, Carlsson A
J Neural Transm. 1985; 62(1-2):1-52.
PMID: 3894582
DOI: 10.1007/BF01260414.
Lack of effects of apomorphine, haloperidol and clozapine on the synthesis and utilization of brain GABA.
Lindgren S
J Neural Transm. 1987; 69(1-2):47-57.
PMID: 3585320
DOI: 10.1007/BF01244096.
Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
Barton A, Moore K, Demarest K
J Neural Transm. 1987; 68(1-2):25-39.
PMID: 2879883
DOI: 10.1007/BF01244637.
The effect of the dopamine agonist pergolide on tyrosine hydroxylase activity in rat striatal and limbic miniprisms in vitro: a model for the dopamine autoreceptor?.
Vulto A, Fowler C
Naunyn Schmiedebergs Arch Pharmacol. 1986; 333(4):349-53.
PMID: 2877399
DOI: 10.1007/BF00500008.
Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?.
Fowler C, THORELL G, Andersson M, Magnusson O
Naunyn Schmiedebergs Arch Pharmacol. 1985; 331(1):12-9.
PMID: 2866447
DOI: 10.1007/BF00498846.
B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptors.
ANDEN N, Grabowska-Anden M
J Neural Transm Gen Sect. 1990; 79(3):209-14.
PMID: 2136999
DOI: 10.1007/BF01245131.
An evaluation of apomorphine action on doapminergic receptors.
DANDIYA P, Sharma H, Patni S, Gambhir R
Experientia. 1975; 31(12):1441-3.
PMID: 1213069
DOI: 10.1007/BF01923234.
